Cover Image

Optimizing the speed of intravenous immunoglobulin infusion for Kawasaki Disease

Saved in:

Bibliographic Details
Main Author:	Chia-Yi Chin, MD, MS (Author)
Format:	Book
Published:	Elsevier, 2024-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety associated with the infusion speed of intravenous immunoglobulin for the treatment of Kawasaki disease: a randomized controlled trial
by: Saori Fukui, et al.
Published: (2021)

The efficacy and safety of intravenous immunoglobulin infusion in 12 h for the initial treatment of Kawasaki disease
by: Satoshi Asano, et al.
Published: (2024)

Intravenous Immunoglobulin Resistant Kawasaki Disease
by: Mohammad Reza Navaeifar, et al.
Published: (2013)

Intravenous Immunoglobulin Resistant Kawasaki Disease
by: Mohammad Reza Navaeifar, et al.
Published: (2013)

Hemolytic anemia associated with intravenous immunoglobulin in Kawasaki disease
by: Eun Jung Cheon, et al.
Published: (2024)

Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease
by: Hyo Min Park, et al.
Published: (2013)

Predictors and management of intravenous immunoglobulin-resistant Kawasaki disease
by: Min Seob Song
Published: (2019)

Multiple intravenous antibiotics usage is associated with intravenous immunoglobulin resistance in Kawasaki disease
by: Zon-Min Lee, et al.
Published: (2022)

White Blood Cell and Neutrophil Counts and Response to Intravenous Immunoglobulin in Kawasaki Disease
by: Taichiro Muto MD, PhD, et al.
Published: (2019)

Hemolysis From Intravenous Immunoglobulin in Obese Patients With Kawasaki Disease
by: Khanh-Van Y. Van Anh, et al.
Published: (2020)

Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease
by: Yaheng Lu, et al.
Published: (2021)

Peripheric arterial aneurisyms and monocytosis in intravenous immunoglobulin treatment resistant Kawasaki disease
by: Baskin E, et al.
Published: (2008)

Thrombospondin-2 predicts response to treatment with intravenous immunoglobulin in children with Kawasaki disease
by: Shuai Yang, et al.
Published: (2018)

The characteristic laboratory findings of non-responsiveness to intravenous immunoglobulin in children with Kawasaki disease
by: Han Gil Cho, et al.
Published: (2010)

Predictive factors of resistance to intravenous immunoglobulin and coronary artery lesions in Kawasaki disease
by: Hye Young Lee, et al.
Published: (2016)

Clinical characteristics of aseptic meningitis induced by intravenous immunoglobulin in patients with Kawasaki disease
by: Matsuura Hiroyuki, et al.
Published: (2011)

Relationship between vitamin D levels and intravenous immunoglobulin resistance in Kawasaki disease
by: Jae Sung Jun, et al.
Published: (2017)

A comparison of efficacy of six prediction models for intravenous immunoglobulin resistance in Kawasaki disease
by: Weiguo Qian, et al.
Published: (2018)

Timing of Intravenous Immunoglobulin Treatment and Risk of Coronary Artery Abnormalities in Children with Kawasaki Disease
by: Aswine K. Bal, et al.
Published: (2014)

Meta-analysis of factors predicting resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease
by: Jin-Young Baek, et al.
Published: (2016)

Risk Factors and Predictive Models for Intravenous Immunoglobulin Resistance in Children with Recurrent Kawasaki Disease
by: Chen X, et al.
Published: (2022)

Transfusion-Related Acute Lung Injury After Immunoglobulin Infusion for Kawasaki Disease: A Case Report and Literature Review
by: Judy Ibrahim MBBS, et al.
Published: (2017)

Immunoglobulin-resistant Kawasaki disease
by: Bibiana Marriaga-Núñez, et al.
Published: (2023)

Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial
by: Ho-Chang Kuo, et al.
Published: (2018)

Importance of predicting non-response to intravenous immunoglobulin therapy in non-Asian patients with Kawasaki disease
by: Isabelle Koné-Paut, et al.
Published: (2022)

Prediction of unresponsiveness to second intravenous immunoglobulin treatment in patients with Kawasaki disease refractory to initial treatment
by: Euri Seo, et al.
Published: (2016)

Intravenous immunoglobulin-resistant Kawasaki disease: Risk factors in children in a middle-income country
by: Norazah Zahari, et al.
Published: (2023)

Comparison of Machine Learning Models for Prediction of Initial Intravenous Immunoglobulin Resistance in Children With Kawasaki Disease
by: Yasutaka Kuniyoshi, et al.
Published: (2020)

Effect of Early Intravenous Immunoglobulin Therapy in Kawasaki Disease: A Systematic Review and Meta-Analysis
by: Fan Yan, et al.
Published: (2020)

Predictive value of albumin for intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients
by: Rui Zhang, et al.
Published: (2023)

FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease
by: Ho-Chang Kuo, et al.
Published: (2015)

EXPERIENCE OF INTRAVENOUS INJECTION OF NORMAL HUMAN IMMUNOGLOBULIN IN A PATIENT WITH KAWASAKI SYNDROME
by: T. V. Sleptsova, et al.
Published: (2014)

Relationship between ocular manifestations, laboratory findings, echocardiographic findings, and intravenous immunoglobulin resistance in Kawasaki disease
by: Mohsen Jari, et al.
Published: (2024)

Impact of Early Treatment with High-Dose Intravenous Immunoglobulin on Incidence of Kawasaki Disease Complications in Iranian Children
by: Alireza Karimi Yazdi, et al.
Published: (2021)

A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
by: Wei Li, et al.
Published: (2021)

A decision tree model for predicting intravenous immunoglobulin resistance and coronary artery involvement in Kawasaki disease
by: Jinwoon Joung, et al.
Published: (2022)

Circulating Immune Cell Profile and Changes in Intravenous Immunoglobulin Responsiveness Over the Disease Course in Children With Kawasaki Disease
by: In Su Choi, et al.
Published: (2022)

Treatment of Kawasaki Disease: A Network Meta-Analysis of Four Dosage Regimens of Aspirin Combined With Recommended Intravenous Immunoglobulin
by: Ying-Hua Huang, et al.
Published: (2021)

NLRC4 methylation and its response to intravenous immunoglobulin therapy in Kawasaki disease: a case control study
by: Beirong Yu, et al.
Published: (2024)

Construction and validation of predictive models for intravenous immunoglobulin-resistant Kawasaki disease using an interpretable machine learning approach
by: Linfan Deng, et al.
Published: (2024)